Open Access
- 18 January 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 790
Abstract
Galectins are widely distributed throughout the animal kingdom, from marine sponges to mammals. Galectins are a family of soluble lectins that specifically recognize β-galactoside-containing glycans and are categorized into three subgroups based on the number and function of their carbohydrate recognition domains (CRDs). The interaction of galectins with specific ligands mediates a wide range of biological activities, depending on the cell type, tissue context, expression levels of individual galectin, and receptor involvement. Galectins affect various immune cell processes through both intracellular and extracellular mechanisms and play roles in processes, such as apoptosis, angiogenesis, and fibrosis. Their importance has increased in recent years because they are recognized as biomarkers, therapeutic agents, and drug targets, with many other applications in conditions such as cardiovascular diseases and cancer. However, little is known about the involvement of galectins in liver diseases. Here, we review the functions of various galectins and evaluate their roles in liver diseases.Keywords
All Related Versions
This publication has 169 references indexed in Scilit:
- Association Between Serum Galectin‐3 and Parkinson's Disease: A Two‐Sample Mendelian Randomization StudyBrain and Behavior, 2024
- Galectin‐1–RNA interaction map reveals potential regulatory roles in angiogenesisFEBS Letters, 2021
- Galectin‐9: Diverse roles in hepatic immune homeostasis and inflammationHepatology, 2017
- State of the Art: Newer Biomarkers in Heart FailureEuropean Journal of Heart Failure, 2015
- Gal‐3 regulates the capacity of dendritic cells to promote NKT‐cell‐induced liver injuryEuropean Journal of Immunology, 2014
- Galectin‐3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1‐induced macrophagesCancer Medicine, 2014
- The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathwayHepatology, 2012
- Galectin-3 deficiency prevents concanavalin A–induced hepatitis in miceHepatology, 2011
- Prognosis in adenocarcinomas of lower oesophagus, gastro‐oesophageal junction and cardia evaluated by uPAR‐immunohistochemistryInternational Journal of Cancer, 2011
- Galectin‐9 expands immunosuppressive macrophages to ameliorate T‐cell‐mediated lung inflammationEuropean Journal of Immunology, 2010